Photo by FG Trade/Getty Images
April 15, 2021
A new health equity initiative from Fitbit is aiming to put research tools into the hands of traditionally underrepresented early career researchers to empower investigations into health disparities.
Announced this week, the Health Equity Research Initiative will award up to $500,000 in Fitbit products and services to researchers looking specifically at health inequalities in underserved...
(Photo by Sebastian Kaulitzki/Getty Images)
April 1, 2021
Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences.
The startup and its CEO Ed Cox became one of the developing space's many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimer's symptoms treatment, with Cox chairing a handful of industry...
(Photo by Sundry Photography/Getty Images)
March 29, 2021
On Thursday, Amazon landed an FDA Emergency Use Authorization for its COVID-19 test kit with at-home sample collection.
According to FDA documents, the product is cleared for self-sample collection by nasal swab for individuals aged 18 years and over. The kit can be used either under the supervision of a healthcare provider or unsupervised at home. The kit includes a nasal swab, a collection tube...
(Image courtesy of Akili Interactive)
March 29, 2021
Akili Interactive has published the full data from its STARS-ADHD Adjunctive trial. The data builds upon the company's pivotal study of AKL-T01 (now available as EndeavorRx) and suggests the videogame-like digital therapeutic delivers benefits with or without accompanying stimulant medication, and that they persist up to one month following the treatment.
"These results increase the...
(Photo by MR.Cole_Photographer/Getty Images)
March 23, 2021
UK biotech firm Genomics plc is working with the NHS on a pilot study using genetic information to predict patients’ risk of heart disease.
Around 1,000 people in north-east England who attend routine GP health checks, will take part in the trial.
An integrated risk tool (IRT), created by Oxford University spin-off Genomics plc, will be used to estimate each patient's risk of developing...
March 18, 2021
The history of pharma and provider partnerships spans back decades, and has traditionally focused on the development of new drugs. Digital is coming into the fold of health, forcing those partnerships to go through a metamorphosis to include new tech.
“Industry and academia have been working together for decades in a pharmaceutical sector, but historically the relationships did not extend beyond...
March 15, 2021
insitro, an artificial intelligence drug discovery startup, has added a $400 million Series C round to its already impressive fundraising haul. The financing is set to close during the first full week of April, according to the company.
Canadian Pension Plan Investment Board led the raise, which also included a laundry list of participants. These names include: Andreessen Horowitz, funds and...
March 10, 2021
Ibex Medical Analytics, an Israel-based startup using artificial intelligence to support cancer diagnostics, has unveiled a $38 million Series B funding round. Octopus Ventures and 83North led the raise, which also saw participation from aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital.
WHAT IT DOES
Ibex's Galen platform uses AI and machine learning to reduce the burden on...
Photo courtesy of Highmark
March 2, 2021
In December, Highmark Health announced a six-year collaboration with Google Cloud that the companies said would lay down the infrastructure of the integrated delivery network's data-driven Living Health Dynamic Platform.
Today, the organizations unveiled plans to get Verily and its Onduo chronic care subsidiary in on the action as well. Through another six-year partnership, the partners will work...
February 1, 2021
UK video-consultation platform, Push doctor has partnered with independent UK pharmacy chain, Well Pharmacy to launch a pharmacy-based digital service.
The pilot, initially run at a single GP practice for four weeks, has now been extended to a further three GP practices across Plymouth Sound primary care network and is currently available to over 50,000 patients living in the local area.